When your lungs start to stiffen and scar, breathing doesn’t just get harder-it becomes a daily struggle. Interstitial lung disease (ILD) isn’t one condition. It’s a group of more than 200 disorders that slowly destroy the delicate tissue between your air sacs, turning flexible lung tissue into stiff, scarred muscle. This isn’t just about getting winded after climbing stairs. For many, it’s about not being able to talk without stopping for air, or waking up at night because your body can’t get enough oxygen. And once the scarring sets in, it doesn’t go away.
What Exactly Happens in the Lungs?
Your lungs are made up of millions of tiny air sacs called alveoli. Between them is a thin layer of tissue-the interstitium. In healthy lungs, this layer is thinner than a sheet of paper. In ILD, it thickens. Not from swelling, but from scar tissue building up like internal fibrosis. This makes the lungs rigid, like a worn-out rubber band. They can’t expand properly. Oxygen can’t move into the bloodstream the way it should.
The result? Your body starves for air. You feel tired. You cough nonstop-not because of mucus, but because your lungs are irritated. Your fingertips may widen and round out, a sign called clubbing. Your oxygen levels drop below 88%, even at rest. Simple tasks like brushing your teeth or walking to the mailbox become exhausting. About 92% of people with ILD report shortness of breath as their first and most persistent symptom.
Idiopathic Pulmonary Fibrosis: The Most Common Form
Of all ILD types, idiopathic pulmonary fibrosis (IPF) is the most frequent, making up 20-30% of cases. It’s called "idiopathic" because no clear cause is found. It mostly affects people over 60, especially those who’ve smoked or had long-term exposure to dust or fumes. IPF doesn’t come on suddenly. It creeps in. At first, you think you’re just out of shape. Then, you notice you’re breathing harder than your friends during a walk. By the time you see a doctor, the scarring has already progressed.
Without treatment, the average survival time after diagnosis is just 3 to 5 years. But that number is changing. Thanks to new drugs, many people are living longer-with better quality of life.
How Is ILD Diagnosed?
ILD is often mistaken for asthma, heart failure, or just aging. On average, people see three different doctors before getting the right diagnosis. It takes about 11 months from when symptoms start to when a final diagnosis is made.
The gold standard for diagnosis is a high-resolution CT scan (HRCT) with 1mm slices. This isn’t a regular chest X-ray. It shows the fine details of lung scarring. In many cases, doctors also need a lung biopsy, but now, a multidisciplinary team of pulmonologists, radiologists, and pathologists can often make a confident diagnosis without surgery, just by reviewing the scan and symptoms together.
Recent advances include blood tests for the MUC5B gene mutation. If you have this variant, your risk of developing IPF is much higher. It’s now used in high-risk groups like smokers or people with autoimmune diseases to catch ILD before symptoms get severe.
Treatment: Slowing the Scarring, Not Reversing It
There’s no cure for ILD. But there are ways to slow it down. The biggest breakthrough in the last decade has been antifibrotic drugs-medications that stop scar tissue from forming.
Two drugs are now standard for IPF: nintedanib (Ofev®) and pirfenidone (Esbriet®). Both were approved in the U.S. between 2014 and 2015. In clinical trials, they cut the rate of lung function decline by about half over one year. That means patients lose less lung capacity. They can walk farther, breathe easier, and stay out of the hospital.
Nintedanib is taken as two pills daily. Pirfenidone is taken three times a day with food. Both cause side effects. About 65% of people on pirfenidone get sunburned easily-even on cloudy days. Many also get nausea, vomiting, or loss of appetite. Dose adjustments are common. Nintedanib can cause diarrhea, but most people adjust after a few weeks.
These drugs don’t work for all types of ILD. If your ILD is caused by rheumatoid arthritis or another autoimmune disease, these medications may not help much. That’s why knowing the exact subtype matters.
Other Treatments and Supportive Care
When oxygen levels drop below 88%, supplemental oxygen becomes necessary. About 55% of IPF patients need it within two years of diagnosis. Oxygen therapy isn’t just for nighttime-it’s often needed during the day, even for short walks. Portable oxygen tanks have gotten lighter and quieter. Many patients now use lightweight concentrators that fit in a backpack.
Pulmonary rehabilitation is one of the most effective tools. It’s not just exercise. It’s a 8- to 12-week program with trained specialists. You learn how to breathe efficiently, how to pace yourself, and how to use energy wisely. People who complete the program improve their walking distance by 45 to 60 meters on average. They report less anxiety, better sleep, and more confidence.
For some, lung transplant is the only option. It’s not for everyone-you need to be young enough, healthy enough, and have strong social support. But for those who qualify, it can add years of life.
What’s New in 2026?
The landscape changed in late 2023 with the FDA approval of zampilodib, the first new antifibrotic drug since 2014. Unlike nintedanib and pirfenidone, zampilodib targets a different pathway in scar formation. In trials, it reduced lung function decline by 48% compared to placebo. It’s now approved for progressive pulmonary fibrosis, even if it’s not IPF.
Artificial intelligence is also helping. Mayo Clinic’s AI tool analyzes HRCT scans and spots early scarring patterns that even expert radiologists miss. In tests, it was 92% accurate-compared to 78% for humans. This means patients can be diagnosed earlier, when treatment is most effective.
Researchers are now testing combination therapies, stem cell treatments, and drugs that target specific genes linked to ILD. Over 14 genes have been identified so far. In the next five years, we may see personalized treatment plans based on your genetic profile.
Living with ILD: Real Challenges
Patients don’t just fight scarring-they fight isolation. Nearly 70% say they’ve stopped going out because they need oxygen or fear getting winded. Family caregivers spend an average of 20 hours a week helping with oxygen equipment, mobility, and appointments. The emotional toll is heavy.
Many report being told their symptoms are "just aging" or "anxiety." That delays diagnosis by years. If you’re over 60 and have a persistent dry cough or unexplained shortness of breath, ask for a high-resolution CT scan. Don’t wait.
Support groups make a difference. People who join ILD communities report better mental health and more confidence managing their condition. Knowledge is power-and you’re not alone.
What to Do Next
If you or someone you care about has unexplained breathlessness, persistent cough, or fatigue that doesn’t improve:
- See a pulmonologist-not just your primary care doctor.
- Ask for a high-resolution CT scan of the lungs.
- Request testing for MUC5B gene mutation if you’re over 60 or have a history of smoking.
- Consider pulmonary rehabilitation even if you’re not severely limited.
- Learn about oxygen therapy options before you’re forced into emergency use.
ILD is not a death sentence. It’s a chronic condition-and like diabetes or heart disease, it can be managed. The key is early detection, accurate diagnosis, and starting treatment before the scarring takes over.
Can interstitial lung disease be cured?
No, there is currently no cure for ILD. The scarring in the lungs is permanent. However, treatments like nintedanib, pirfenidone, and zampilodib can slow the progression of lung damage. Pulmonary rehabilitation, oxygen therapy, and lifestyle changes can also help maintain quality of life and delay worsening symptoms.
How long do people live with interstitial lung disease?
Life expectancy varies widely depending on the type. For idiopathic pulmonary fibrosis (IPF), untreated patients typically live 3 to 5 years after diagnosis. With antifibrotic therapy, many live longer-some beyond 7 years. Other forms, like sarcoidosis or connective tissue disease-related ILD, may progress slowly or even stabilize. Early diagnosis and treatment are the biggest factors in improving survival.
Is ILD the same as COPD or asthma?
No. COPD (chronic obstructive pulmonary disease) and asthma involve airway narrowing and inflammation, often reversible with inhalers. ILD affects the lung tissue itself-specifically the interstitium-causing irreversible scarring. Symptoms like shortness of breath can feel similar, but the underlying damage and treatment approaches are completely different. A CT scan is needed to tell them apart.
Can smoking cause interstitial lung disease?
Yes. Smoking is a major risk factor for idiopathic pulmonary fibrosis (IPF) and can worsen other forms of ILD. It also increases the risk of developing lung scarring after exposure to dust, chemicals, or radiation. Quitting smoking at any stage can slow disease progression and improve response to treatment.
What are the side effects of nintedanib and pirfenidone?
Nintedanib commonly causes diarrhea, nausea, and abdominal pain. Pirfenidone often leads to sun sensitivity (photosensitivity), nausea, vomiting, and loss of appetite. Most side effects improve after the first few weeks. Doctors usually start with lower doses and increase slowly. Sunscreen and protective clothing are essential for those on pirfenidone.
Can I still exercise with ILD?
Yes-and you should. Exercise helps maintain muscle strength, breathing efficiency, and mental health. Pulmonary rehab programs are designed specifically for ILD patients. They teach you how to pace yourself, use oxygen during activity, and avoid overexertion. Even walking 10 minutes a day, with oxygen if needed, can make a difference.
Is ILD hereditary?
Most cases are not inherited. But about 10% of IPF cases occur in families with a history of lung scarring. Researchers have identified 14 genes linked to higher risk, including MUC5B and TERC. Genetic testing is now available for people with family history or early-onset ILD.
What should I do if I’m diagnosed with ILD?
Seek care at a specialized ILD center if possible. Ask for a multidisciplinary evaluation. Start antifibrotic therapy if recommended. Join a pulmonary rehab program. Get vaccinated against flu and pneumonia. Avoid lung irritants like smoke, dust, and chemicals. Connect with support groups. And don’t delay-early action gives you the best chance to preserve lung function.